Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
203.66
+2.83 (1.41%)
At close: Jul 19, 2024, 4:00 PM
203.71
+0.05 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $5.82 billion as of July 22, 2024. Its market cap has increased by 85.79% in one year.
Market Cap
5.82B
Enterprise Value
5.29B
1-Year Change
85.79%
Ranking
Category
Stock Price
$203.66
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $5.82B, an increase of 6,194.59%. That is a compound annual growth rate of 83.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 5.82B | 66.21% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 6.12B |
| Glaukos | 6.08B |
| Acadia Healthcare Company | 6.05B |
| Bausch + Lomb | 5.96B |
| Stevanato Group | 5.83B |
| Masimo | 5.68B |
| Viking Therapeutics | 5.61B |
| R1 RCM | 5.60B |